BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Little C, Cosetti MK. A Narrative Review of Pharmacologic Treatments for COVID-19: Safety Considerations and Ototoxicity. Laryngoscope 2021;131:1626-32. [PMID: 33491234 DOI: 10.1002/lary.29424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sadiq AM, Katundu DR, Akrabi HF. A case of sudden mixed hearing loss in SARS-CoV-2. SAGE Open Medical Case Reports 2022;10:2050313X2210806. [DOI: 10.1177/2050313x221080642] [Reference Citation Analysis]
2 Yang S, Shen S, Hou N. Is Ivermectin Effective in Treating COVID-19? Front Pharmacol 2022;13:858693. [DOI: 10.3389/fphar.2022.858693] [Reference Citation Analysis]
3 Kebria MM, Milan PB, Peyravian N, Kiani J, Khatibi S, Mozafari M. Stem cell therapy for COVID-19 pneumonia. Mol Biomed 2022;3:6. [PMID: 35174448 DOI: 10.1186/s43556-021-00067-8] [Reference Citation Analysis]
4 Bozdemir K, Çallıoğlu EE, İslamoğlu Y, Ercan MK, Eser F, Özdem B, Kıraç A, Bayazıt D, Güner R, Babademez MA. Evaluation of the effects of Covid-19 on cochleovestibular system with audiovestibular tests. Ear Nose Throat J 2022;:1455613211069916. [PMID: 34991362 DOI: 10.1177/01455613211069916] [Reference Citation Analysis]
5 Ceccarelli M, Marino A, Pulvirenti S, Coco V, Busà B, Nunnari G, Cacopardo BS. Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital. Infectious Disease Reports 2022;14:372-82. [DOI: 10.3390/idr14030041] [Reference Citation Analysis]
6 Ferreira RJDS, Barboza HN, Araújo ALDLES, Paiva SFD, Rosa MRDD. Auditory and vestibular symptoms after COVID-19 infection: a preliminary Brazilian report. Rev CEFAC 2021;23:e8121. [DOI: 10.1590/1982-0216/20212368121] [Reference Citation Analysis]
7 Fancello V, Hatzopoulos S, Corazzi V, Bianchini C, Skarżyńska MB, Pelucchi S, Skarżyński PH, Ciorba A. SARS-CoV-2 (COVID-19) and audio-vestibular disorders. Int J Immunopathol Pharmacol 2021;35:20587384211027373. [PMID: 34142589 DOI: 10.1177/20587384211027373] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The role of type I interferon in the treatment of COVID-19. J Med Virol 2021. [PMID: 34468995 DOI: 10.1002/jmv.27317] [Reference Citation Analysis]
9 Narozny W, Tretiakow D, Skorek A. In Reference to The Challenges of Pharmacotherapy of SARS-CoV-2 Infection in Patients With Sudden Sensorineural Hearing Loss Due to COVID-19. Laryngoscope 2021;131:E2335. [PMID: 33729578 DOI: 10.1002/lary.29514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Coffin AB, Boney R, Hill J, Tian C, Steyger PS. Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings. Front Neurol 2021;12:725566. [PMID: 34489859 DOI: 10.3389/fneur.2021.725566] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Little C, Cosetti MK. In Response to The Challenges of Pharmacotherapy of SARS-CoV-2 Infection in Patients with Sudden Sensorineural Hearing Loss Due to COVID-19. Laryngoscope 2021;131:E2336. [PMID: 33729582 DOI: 10.1002/lary.29517] [Reference Citation Analysis]
12 Gedik Ö, Hüsam H, Başöz M, Tas N, Aksoy F. The effect of coronavirus disease 2019 on the hearing system. J Laryngol Otol 2021;135:810-4. [PMID: 34344488 DOI: 10.1017/S0022215121001961] [Reference Citation Analysis]